Matches in Wikidata for { <http://www.wikidata.org/entity/Q96178902> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q96178902 description "clinical trial" @default.
- Q96178902 description "ensayo clínico" @default.
- Q96178902 description "ensayu clínicu" @default.
- Q96178902 description "klinisch onderzoek" @default.
- Q96178902 description "клінічне випробування" @default.
- Q96178902 description "临床试验" @default.
- Q96178902 name "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 name "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 type Item @default.
- Q96178902 label "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 label "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 prefLabel "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 prefLabel "Phase 1 Safety, Tolerability, PK & PD Study of AD-214 Administered to Healthy Volunteers and Patients With ILD" @default.
- Q96178902 P1132 Q96178902-4785EAEC-AD29-4270-BE23-634F49FC6A02 @default.
- Q96178902 P1476 Q96178902-FCA02585-5405-482C-89BA-97F6F77909D9 @default.
- Q96178902 P2899 Q96178902-9A52F55D-F1F6-420A-BFAF-F09E24A3E65B @default.
- Q96178902 P3098 Q96178902-A9D28AA5-CD70-4674-9F4A-1BC6B0622232 @default.
- Q96178902 P31 Q96178902-F566D381-DFEE-45E9-9938-CFD9ED2A4181 @default.
- Q96178902 P4135 Q96178902-4EF81298-F8FF-415B-AE6C-6A199C21D34C @default.
- Q96178902 P580 Q96178902-4BB7446D-6553-4055-9DE8-8BE32D1666E1 @default.
- Q96178902 P582 Q96178902-4BDAF16A-2BE5-4BA6-849E-4476FD1BC097 @default.
- Q96178902 P6099 Q96178902-CA4216B7-8C6A-49A7-A13E-7EAA506E5815 @default.
- Q96178902 P8005 Q96178902-38CD12F0-6AB7-4642-9AB6-3D4CB0A2747E @default.
- Q96178902 P8363 Q96178902-4178079C-3D42-42CD-A57D-782648D41D76 @default.
- Q96178902 P1132 "+94" @default.
- Q96178902 P1476 "A Phase 1, Dose-escalating Study of the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Doses of AD-214 When Administered Intravenously to Healthy Volunteers and to Patients With Interstitial Lung Disease" @default.
- Q96178902 P2899 "+18" @default.
- Q96178902 P3098 "NCT04415671" @default.
- Q96178902 P31 Q30612 @default.
- Q96178902 P4135 "+65" @default.
- Q96178902 P580 "2020-07-19T00:00:00Z" @default.
- Q96178902 P582 "2022-07-31T00:00:00Z" @default.
- Q96178902 P6099 Q5452194 @default.
- Q96178902 P8005 Q76649614 @default.
- Q96178902 P8363 Q78089383 @default.